Table 1.

Demographic characteristics of study participants at baseline. Data were means ± s.d. or medians (interquartile ranges) for skewed variables or numbers (proportions) for categorical variables.

	Sitagliptin (N = 93)	Vildagliptin (N = 94)	Saxagliptin (N = 90)	P value
Age (years)	55.1 ± 9.3	49.3 ± 10.0	48.7 ± 11.2	0.02
BMI (kg/m2)	27.0 ± 3.4	26.8 ± 3.1	27.1 ± 2.9	0.93
TC (mmol/L)	5.1 (4.4–5.6)	5.0 (4.2–5.5)	5.1 (4.6–6.0)	0.74
LDL-C (mmol/L)	3.3 ± 0.8	3.0 ± 0.9	3.3 ± 0.9	0.56
HDL-C (mmol/L)	1.2 ± 0.3	1.3 ± 0.5	1.3 ± 1.2	0.87
FPG (mmol/L)	8.3 ± 1.6	9.0 ± 2.6	8.4 ± 1.6	0.40
PPG (mmol/L)	14.9 ± 4.9	16.1 ± 5.5	13.3 ± 4.6	0.17
HbA1c (%)	7.10 (6.70–7.80)	7.50 (6.90–8.00)	7.40 (6.80–7.90)	0.26
ALT (IU/L)	22.1 (16.0–31.5)	20.0 (17.1–32.0)	24.0 (19.2–38.0)	0.11
AST (IU/L)	18.0 (15.0–23.0)	17.0 (14.4–22.0)	20.0 (16.0–26.0)	0.68
Cr (µmol/L)	64.4 ± 16.4	67.61 ± 17.0	62.2 ± 10.3	0.41
BIL (µmol/L)	19.6 ± 30.6	14.2 ± 6.5	16.4 ± 6.4	0.61
WBC (109/L)	5.9 ± 1.0	6.5 ± 1.4	6.5 ± 1.7	0.24

P value was calculated for Chi-square test across the three groups.

BIL, total bilirubin; BMI, body mass index; Cr, creatine; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; WBC, white blood cell.